These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8514883)

  • 1. Endotoxin-induced pulmonary dysfunction is prevented by C1-esterase inhibitor.
    Guerrero R; Velasco F; Rodriguez M; Lopez A; Rojas R; Alvarez MA; Villalba R; Rubio V; Torres A; del Castillo D
    J Clin Invest; 1993 Jun; 91(6):2754-60. PubMed ID: 8514883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1-esterase inhibitor prevents early pulmonary dysfunction after lung transplantation in the dog.
    Salvatierra A; Velasco F; Rodriguez M; Alvarez A; Lopez-Pedrera R; Ramirez R; Carracedo J; Lopez-Rubio F; Lopez-Pujol J; Guerrero R
    Am J Respir Crit Care Med; 1997 Mar; 155(3):1147-54. PubMed ID: 9117001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock.
    Jansen PM; Eisele B; de Jong IW; Chang A; Delvos U; Taylor FB; Hack CE
    J Immunol; 1998 Jan; 160(1):475-84. PubMed ID: 9552006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy.
    Hack CE; Ogilvie AC; Eisele B; Jansen PM; Wagstaff J; Thijs LG
    Prog Clin Biol Res; 1994; 388():335-57. PubMed ID: 7831367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined antithrombin III and C1-esterase inhibitor treatment decreases intravascular fibrin deposition and attenuates cardiorespiratory impairment in rabbits exposed to Escherichia coli endotoxin.
    Giebler R; Schmidt U; Koch S; Peters J; Scherer R
    Crit Care Med; 1999 Mar; 27(3):597-604. PubMed ID: 10199542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of C1-inhibitor on inflammation, edema and shock.
    Dickneite G
    Behring Inst Mitt; 1993 Dec; (93):299-305. PubMed ID: 8172580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of C1-esterase inhibitor on tissue oxygenation of jejunal mucosa during endotoxemia.
    Schmidt W; Stenzel K; Walther A; Gebhard MM; Martin E; Schmidt H
    Int J Surg Investig; 1999; 1(4):277-83. PubMed ID: 12774449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
    J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates.
    Tassani P; Kunkel R; Richter JA; Oechsler H; Lorenz HP; Braun SL; Eising GP; Haas F; Paek SU; Bauernschmitt R; Jochum M; Lange R
    J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):469-73. PubMed ID: 11505352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.
    Fischer MB; Prodeus AP; Nicholson-Weller A; Ma M; Murrow J; Reid RR; Warren HB; Lage AL; Moore FD; Rosen FS; Carroll MC
    J Immunol; 1997 Jul; 159(2):976-82. PubMed ID: 9218619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of C1-inactivator (C1-INA) on endotoxin shock].
    Kawamata K; Omi S; Kubota T
    Kokyu To Junkan; 1988 Apr; 36(4):429-33. PubMed ID: 3399748
    [No Abstract]   [Full Text] [Related]  

  • 12. C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.
    Hack CE; Ogilvie AC; Eisele B; Eerenberg AJ; Wagstaff J; Thijs LG
    Intensive Care Med; 1993; 19 Suppl 1():S19-28. PubMed ID: 8053997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.
    Kalter ES; Daha MR; ten Cate JW; Verhoef J; Bouma BN
    J Infect Dis; 1985 Jun; 151(6):1019-27. PubMed ID: 2582065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failure.
    Quezado ZM; Hoffman WD; Winkelstein JA; Yatsiv I; Koev CA; Cork LC; Elin RJ; Eichacker PQ; Natanson C
    J Exp Med; 1994 Feb; 179(2):569-78. PubMed ID: 8294868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vascular permeability by antisense-mediated inhibition of plasma kallikrein and coagulation factor 12.
    Bhattacharjee G; Revenko AS; Crosby JR; May C; Gao D; Zhao C; Monia BP; MacLeod AR
    Nucleic Acid Ther; 2013 Jun; 23(3):175-87. PubMed ID: 23582057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of C3c, C4 and C1-esterase inhibitor (C1-INH) during unstable angina].
    Danese C; Marcianò F; Ciarla MV; Colotto M; Angrisani L; Ferranti E; Borgia MC
    Minerva Cardioangiol; 2002 Dec; 50(6):667-72. PubMed ID: 12473987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement factor 1 inhibitor improves cardiopulmonary function in neonatal cardiopulmonary bypass.
    Baig K; Nassar R; Craig DM; Quick G; Jiang HX; Frank MM; Lodge AJ; Anderson PA; Jaggers J
    Ann Thorac Surg; 2007 Apr; 83(4):1477-82; discussion 1483. PubMed ID: 17383361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiopulmonary changes with intermittent endotoxin administration in sheep.
    Godsoe A; Kimura R; Herndon D; Flynn JT; Schlag G; Traber L; Traber D
    Circ Shock; 1988 Jun; 25(2):61-74. PubMed ID: 3292076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Septic shock after liver transplantation for Caroli's disease: clinical improvement after treatment with C1-esterase inhibitor.
    Marx G; Nashan B; Cobas Meyer M; Vangerow B; Schlitt HJ; Ziesing S; Leuwer M; Piepenbrock S; Rueckoldt H
    Intensive Care Med; 1999 Sep; 25(9):1017-20. PubMed ID: 10501763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.
    Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Abbink JJ; Strack van Schijndel RJ; Felt-Bersma RJ; Thijs LG; Hack CE
    Blood; 1988 Dec; 72(6):1841-8. PubMed ID: 3264190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.